Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Rare diseases - a medical condition so obscure that even your doctor has to Google. Despite their name, these diseases ...

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

A Shreveport-Bossier City musician is working tirelessly to better the quality of life for people like her sons, some of whom ...

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit ...

Twenty-one-year-old Sebastien Beauzile was all smiles as he was serenaded with “Happy Birthday” on what he calls his new birthday at Cohen Children’s Medical ...

Researchers studied the efficacy of hydroxyurea at reducing stroke risk in sickle cell anemia, the most common and severe ...

Brixton Hill and Streatham MP Bell Ribeiro-Addy with Brixton blood donation centre manager Rexford Osei-Bonsu at its opening ceremony Clapham and Brixton Hill MP Bell Ribeiro Addy today (13 March) int ...

The Sickle Cell Awareness Foundation, a nonprofit based in South Jamaica, is hosting its third symposium on Friday, April 4.The Sickle Cell Symposium will be held at NYC Health + ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...